Literature DB >> 15720997

Locally recurrent breast cancer after conservation therapy.

Tara L Huston1, Rache M Simmons.   

Abstract

BACKGROUND: Today, the majority of small invasive and noninvasive breast cancers are treated with breast conservation therapy (BCT). The incidence of local-regional recurrence (LRR) after BCT for stage 0, I, and II patients ranges between 5% and 22%.
METHODS: A literature search for BCT, local recurrence, and regional recurrence was performed. Data from over 50 articles pertaining to the characteristics, risk factors, detection, management, and prognosis of these patients with LRR after BCT were collected and analyzed.
RESULTS: Positive margins, high-grade ductal carcinoma in situ (DCIS), young age, and the absence of radiation therapy after BCT increase the risk for LRR. Prognosis at LRR is impacted by invasive versus noninvasive histology, size and stage, method of detection, and involvement of skin and/or axillary lymph nodes. The standard treatment is salvage mastectomy.
CONCLUSIONS: The prognosis for LRR after BCT is favorable compared with patients with postmastectomy chest wall recurrence.

Entities:  

Mesh:

Year:  2005        PMID: 15720997     DOI: 10.1016/j.amjsurg.2004.07.039

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  36 in total

1.  Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

Authors:  Xin Zhou; Alan K Meeker; Kepher H Makambi; Ourania Kosti; Bhaskar V S Kallakury; Mary K Sidawy; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.

Authors:  Xiaosong Yang; You Pan; Zhaojun Qiu; Zhanwen Du; Yao Zhang; Pengyan Fa; Shashank Gorityala; Shanhuai Ma; Shunqiang Li; Ceshi Chen; Hongbing Wang; Yan Xu; Chunhong Yan; Keri Ruth; Zhefu Ma; Junran Zhang
Journal:  Clin Cancer Res       Date:  2018-01-11       Impact factor: 12.531

Review 3.  Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review.

Authors:  Sergio Maluta; Merel Willemijn Kolff
Journal:  Breast Care (Basel)       Date:  2015-10-16       Impact factor: 2.860

4.  Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer surveillance after breast-conserving surgery.

Authors:  Ke-Da Yu; Shuang Li; Zhi-Ming Shao
Journal:  Oncologist       Date:  2011-06-16

Review 5.  Intraoperative Radiotherapy of Breast Cancer and Its Biological Effects.

Authors:  Igor Piotrowski; Katarzyna Kulcenty; Mateusz Wichtowski; Dawid Murawa; Wiktoria Suchorska
Journal:  Breast Care (Basel)       Date:  2017-02-07       Impact factor: 2.860

Review 6.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

Review 7.  Breast cancer: Actual methods of treatment and future trends.

Authors:  Paweł Murawa; Dawid Murawa; Beata Adamczyk; Karol Połom
Journal:  Rep Pract Oncol Radiother       Date:  2014-01-23

8.  Significance of ipsilateral breast tumor recurrence after breast conserving treatment: role of surgical removal.

Authors:  Romano Demicheli; Ilaria Ardoino; Federico Ambrogi; Roberto Agresti; Elia Biganzoli
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

9.  c-myc amplifications in primary breast carcinomas and their local recurrences.

Authors:  S Aulmann; N Adler; J Rom; B Helmchen; P Schirmacher; H P Sinn
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

Review 10.  Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology.

Authors:  Céline Bourgier; Mahmut Ozsahin; David Azria
Journal:  Radiat Oncol       Date:  2010-01-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.